News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
604,599 Results
Type
Article (25564)
Company Profile (172)
Press Release (578740)
Multimedia
Podcasts (248)
Webinars (29)
Section
Business (206524)
Career Advice (1744)
Deals (31798)
Drug Delivery (141)
Drug Development (62241)
Employer Resources (190)
FDA (12457)
Job Trends (12614)
News (293145)
Policy (24749)
Tag
2027 BioCapital Standard (1)
2027 BioMidwest Elite (1)
2027 Bio NC Standard (1)
2027 Biotech Bay Elite (4)
2027 Biotech Bay Standard (4)
2027 Biotech Beach Elite (1)
2027 Genetown Elite (3)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Premier (1)
2027 Pharm Country Standard (5)
Academia (1277)
Academic (1)
Accelerated approval (43)
ADA (29)
Adcomms (18)
Allergies (127)
Alliances (42866)
ALS (152)
Alzheimer's disease (1342)
Antibody-drug conjugate (ADC) (418)
Approvals (12830)
Artificial intelligence (679)
ASCO (225)
Autoimmune disease (279)
Automation (57)
Bankruptcy (313)
Best Places to Work (9238)
BIO (66)
Biologics (3)
BIOSECURE Act (21)
Biosimilars (182)
BioSpace Insights (243)
Biotechnology (111)
Bladder cancer (176)
Brain cancer (48)
Breast cancer (625)
Cancer (4677)
Cardiovascular disease (367)
Career advice (1515)
Career pathing (52)
CAR-T (279)
CDC (45)
Celiac Disease (2)
Cell therapy (798)
Cervical cancer (45)
Clinical research (54963)
Collaboration (1862)
Commercialization (6)
Company closure (6)
Compensation (1538)
Complete response letters (73)
COVID-19 (1494)
CRISPR (100)
C-suite (1171)
Cystic fibrosis (131)
Data (6601)
Decentralized trials (2)
Denatured (100)
Depression (159)
Dermatology (85)
Diabetes (470)
Diagnostics (5542)
Digital health (57)
Diversity (11)
Diversity, equity & inclusion (46)
Drug discovery (341)
Drug pricing (180)
Drug shortages (33)
Duchenne muscular dystrophy (264)
Earnings (81040)
Editorial (73)
Employer branding (25)
Employer resources (159)
Events (103717)
Executive appointments (1087)
FDA (15651)
Fibrodysplasia Ossificans Progressiva (11)
Friedreich's ataxia (23)
Frontotemporal dementia (28)
Funding (1495)
Gene editing (211)
Generative AI (64)
Gene therapy (596)
GLP-1 (840)
Government (2777)
Grass and pollen (3)
Guidances (342)
Healthcare (13230)
Hematology (119)
HIV (71)
Huntington's disease (51)
Idiopathic pulmonary fibrosis (2)
IgA nephropathy (94)
Immunology and inflammation (243)
Immuno-oncology (87)
Indications (191)
Infectious disease (1778)
Inflammatory bowel disease (176)
Inflation Reduction Act (16)
Influenza (106)
Intellectual property (290)
Interviews (283)
IPO (14377)
IRA (50)
Job creations (3565)
Job search strategy (1263)
JPM (66)
Kidney cancer (22)
Labor market (129)
Layoffs (403)
Leadership (47)
Legal (6612)
Licensing (10)
Liver cancer (64)
Longevity (32)
Lung cancer (653)
Lymphoma (320)
Machine learning (52)
Management (56)
Manufacturing (1054)
Marketing (11)
MASH (177)
Medical affairs (1)
Medical device (11192)
Medtech (11370)
Mergers & acquisitions (18726)
Metabolic disorders (1276)
mRNA (196)
Multiple sclerosis (148)
NASH (14)
Neurodegenerative disease (356)
Neuropsychiatric disorders (93)
Neuroscience (2635)
Neurotech (1)
NextGen: Class of 2026 (5151)
Non-profit (1986)
Now hiring (82)
Obesity (589)
Opinion (328)
Ovarian cancer (190)
Pain (216)
Pancreatic cancer (250)
Parkinson's disease (285)
Partnered (37)
Patents (555)
Patient recruitment (594)
Peanut (40)
People (54863)
Pharmaceutical (41)
Pharmacy benefit managers (29)
Phase 1 (17385)
Phase 2 (24378)
Phase 3 (17617)
Pipeline (8953)
Policy (329)
Postmarket research (1822)
Preclinical (7424)
Press Release (64)
Prostate cancer (240)
Psychedelics (76)
Radiopharmaceuticals (313)
Rare diseases (988)
Real estate (5474)
Recruiting (77)
Regulatory (19890)
Reports (74)
Research institute (1324)
Resumes & cover letters (281)
Rett syndrome (45)
RNA editing (19)
RSV (71)
Schizophrenia (158)
Series A (271)
Series B (197)
Service/supplier (7)
Sickle cell disease (94)
Special edition (33)
Spinal muscular atrophy (118)
Sponsored (41)
Startups (3233)
State (1)
Stomach cancer (10)
Supply chain (115)
Tariffs (89)
The Weekly (145)
Vaccines (711)
Venture capital (131)
Weight loss (382)
Women's health (114)
Worklife (26)
Date
Today (70)
Last 7 days (293)
Last 30 days (2058)
Last 365 days (24164)
2026 (15912)
2025 (24262)
2024 (28510)
2023 (32605)
2022 (42608)
2021 (45640)
2020 (42842)
2019 (34787)
2018 (26004)
2017 (25871)
2016 (25048)
2015 (30501)
2014 (26210)
2013 (22160)
2012 (24625)
2011 (24674)
2010 (23512)
Location
Africa (624)
Alabama (84)
Alaska (5)
Arizona (346)
Arkansas (14)
Asia (29126)
Australia (3963)
California (13215)
Canada (3521)
China (997)
Colorado (548)
Connecticut (497)
Delaware (260)
Europe (53502)
Florida (2020)
Georgia (424)
Hawaii (4)
Idaho (55)
Illinois (940)
India (87)
Indiana (468)
Iowa (24)
Japan (493)
Kansas (122)
Kentucky (44)
Louisiana (35)
Maine (39)
Maryland (1449)
Massachusetts (9066)
Michigan (343)
Minnesota (664)
Mississippi (7)
Missouri (111)
Montana (25)
Nebraska (23)
Nevada (129)
New Hampshire (79)
New Jersey (3090)
New Mexico (22)
New York (3293)
North Carolina (1599)
North Dakota (9)
Northern California (6650)
Ohio (393)
Oklahoma (22)
Oregon (26)
Pennsylvania (2434)
Puerto Rico (26)
Rhode Island (43)
South America (893)
South Carolina (83)
South Dakota (1)
Southern California (5397)
Tennessee (156)
Texas (2163)
United States (44556)
Utah (413)
Vermont (2)
Virginia (214)
Washington D.C. (65)
Washington State (1033)
West Virginia (4)
Wisconsin (132)
Wyoming (2)
604,599 Results for "sp industries inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Novartis Canada and SP Quebec Celebrate 16 Years of Partnership Through Annual MS Tri-Challenge Fundraiser
June 24, 2026
·
4 min read
Press Releases
Spero Therapeutics and Innovent Biologics Announce Exclusive License for SP001 (IBI355), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
July 14, 2026
·
10 min read
Press Releases
Innovent Biologics and Spero Therapeutics Announce Exclusive License for IBI355 (SP001), a Phase 2-Ready Third-Generation Anti-CD40L Antibody
July 14, 2026
·
10 min read
Press Releases
Kyverna Therapeutics Announces Initiation of Rolling SPS BLA Submission and Reports First Quarter 2026 Financial Results
May 13, 2026
·
13 min read
Press Releases
Theradaptive Secures FDA Approval to Advance OASIS Trial to Pivotal Study Evaluating OsteoAdapt® SP in Spinal Fusion
April 30, 2026
·
4 min read
Press Releases
Intuitive Announces Expanded Indications for da Vinci SP
December 11, 2025
·
3 min read
Press Releases
Dogwood Therapeutics Announces FDA Acceptance of SP16 Investigational New Drug Application for the Treatment of Chemotherapy Induced Pain and Neuropathy
April 15, 2026
·
5 min read
Deals
Spero bets up to $1.1B for Innovent’s autoimmune antibody
Spero Therapeutics is putting over $1 billion on the line in exchange for rights to develop SP001, an anti-CD40L antibody, for IgG4-related disease. A Phase 2 study is planned for the second quarter of 2027.
July 14, 2026
·
2 min read
·
Tristan Manalac
Press Releases
Dyadic Expands Bio industrial Pipeline with New Proprietary Industrial Enzyme Program
July 16, 2026
·
6 min read
Press Releases
WuXi Biologics Recognized for Industry Top Sustainable Biopharma Practices Empowering the Industry’s Transformation Through Green CRDMO
August 18, 2026
·
8 min read
1 of 60,460
Next
